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During the initial phases of the COVID-19 pandemic, accurate tracking has proven
unfeasible. Initial estimation methods pointed toward case numbers that were much
higher than officially reported. In the CoronaSurveys project, we have been addressing
this issue using open online surveys with indirect reporting. We compare our estimates
with the results of a serology study for Spain, obtaining high correlations (R squared 0.89).
In our view, these results strongly support the idea of using open surveys with indirect
reporting as a method to broadly sense the progress of a pandemic.
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1. INTRODUCTION
During the initial phases of the COVID-19 pandemic, progress tracking viamassive serology testing
has proven to be unfeasible. However, initial estimationmethods suggested that the real numbers of
COVID-19 cases were significantly higher than those officially reported (1). For instance, by April
30th, 2020, the number of confirmed fatalities due to COVID-19 in the US was 66, 028, and the
number of confirmed cases was 1, 080, 303. However, with that number of fatalities the number
of cases must have been no < 4, 784, 637, by simply using the Case-fatality Ratio (CFR) of 1.38%
measured in Wuhan (2).
In the case of Spain, the discrepancy seems to be even higher. Preliminary studies point toward
only one in 53 cases being reported during the first days of the pandemic (3). Although recent
availability of massive testing has reduced this discrepancy, demographic statistics still indicate
a degree of underreporting to this day, which can be seen among others in mortality numbers:
all-cause mortality statistics in Spain point to two periods of significant excess of deaths in
the country over the predicted values in 2020: March and April (44, 599 deaths in excess) and
August to December (26, 186 deaths in excess) (4). These numbers contrast with the officially
reported number of deaths due to COVID-19, which rests at 50, 837 (5). This discrepancy is
corroborated in publications from official government authorities, which indicate an ongoing
estimated underreporting of 20–40% (6).
A potential method to address this limitation is to use online surveys during the initial
stages of pandemics. Online surveys can be deployed quickly and are cost-effective, but show
potential weaknesses in sampling, confidentiality, and other ethical issues (7). In spite of these
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weaknesses, online surveys have already been successfully
implemented in scenarios, such as influenza tracking (8).
In the CoronaSurveys project, Ojo et al. (9) we aim to
track the progress of the COVID-19 pandemic using online,
open, anonymous surveys with indirect reporting. Other recent
articles have also suggested the use of surveys to monitor this
pandemic, both for Spain (10, 11) and globally (12). However,
to our knowledge, all surveys conducted in Spain have employed
direct reporting only, asking participants about themselves.
CoronaSurveys implements the network scale-up method of
indirect reporting instead, allowing us to collect data on a wide
fraction of the population with a small number of responses and
in a very short time-frame (13). In this article, we compare the
accuracy of CoronaSurveys with a gold standard: serology testing
data collected by the Spanish government in the ENE-COVID
study (14).
2. METHODS
The survey deployed in the CoronaSurveys project can be
answered via browser or mobile app. After the participant
indicates the region (Spanish autonomous community) for
which information will be provided, two additional questions
are presented:
1. How many people do you know in your area for which you
know their health condition? The answer to this question by
participant i is the Reach ri.
2. How many of those were diagnosed with or have symptoms of
COVID-19? The answer to this question by participant i is the
Cumulative Number of Cases ci.
In the CoronaSurveys project we have focused on simplicity
and brevity to maximize interest and retain users that would
consistently provide data every few days. For that reason the
total number of questions in the survey has been kept small
at all times. Our approach yielded good initial results with
about 200 responses per week. The survey has been promoted
via social networks, direct contacts, and, more recently, with
paid advertising.
To ensure total anonymity, the surveys are hosted on a private
instance of LimeSurvey (15). Data is aggregated daily, and in this
process the responses are shuffled so no single entry can be back-
traced to its user. All the data is published in a public Github
repository. The study design was reviewed and approved by the
ethics committee of the IMDEA Networks Institute. The survey
includes an informed consent.
Once the data is collected, we remove outlier responses. A
response is considered an outlier if (1) ri is outside 1.5 times the
interquartile range above the upper quartile (which for the data
in this paper means ri > 175) or if (2) ci/ri is > 1/3 (to exclude
participants with an exceptionally high contact with cases).
Although participants may choose to provide information for the
whole country, in this paper we only consider responses in which
participants provide information for their specific region. Hence,
the data is aggregated by region for all participants, to obtain the






To assess the accuracy of this method in estimating the
cumulative number of cases of COVID-19, we compare our
cross-sectional survey estimates with the results of the serology
study of Pollán et al. (14) for Spain. We exclude Ceuta and
Melilla due to lack of data on our part. Conducted between
April 27 and May 11, 2020, the serology study provides data
for n = 61, 075 participants (0.1787 ± 0.0984% of the
regional population, and 0.1299% of the national population).
We consider as positive cases those that tested positive to the
point-of-care or immunoassay IgG tests [Supplementary Table 6
in Pollán et al. (14), column Either test positive].
For our estimates, we consider the (up to) 100 most recent
survey responses per region on April 20. The date is chosen
because the mean period between illness onset and a 95%
confidence of IgG antibodies presence is 14 days (16). This results
in n = 999 responses (59±35 per region) across Spanish regions,
with a cumulative reach of
∑
i ri = 67, 199 (0.1827± 0.0701% of
the regional population, and 0.1434% of the national population).
On average, participants provide information for ri = 74.6219±
38.0291 members in their social circle, which is coherent with
Dunbar’s acquaintance group and related studies that take social
networks into consideration (17). Within this dataset, our outlier
removal methods excluded 19.8883 ± 9.2692% of responses,
including spurious contributions as the original average reach per
participant before filtering was > 5 · 1015.
The Bland-Altman plot in Figure 1B shows a high correlation
between the CoronaSurveys estimates and the gold standard. A
direct comparison of crude percentages, depicted in Figure 1B,
also yields excellent results (R2 = 0.8994). Table 1 presents a
detailed comparison of the estimates per region obtained in the
different studies.
Figure 2A presents how the number of responses per region
affects the resulting value of R2. This analysis indicates that 50
responses per region can already offer a reasonable estimation of
cases. Including more responses may further increase accuracy,
but the numbers remain reasonably stable. Naturally, it is
important that responses are well-distributed across all regions.
Figure 2B depicts the effect of the day limit on R2 if we consider
a date of±1 week. Theoretically, a bell curve centered on the 20th
should be expected, as estimating too early would imply too few
cases are reported, and estimating too late would include more
cases. We indeed observe an impact on accuracy, and the left
half of the bell curve is more visible. The change in accuracy is
mostly due to new daily responses collected on April 16th. The
lack of the right half of the bell curve is due to the low number
of new daily responses after April 16th, which implies that the
daily estimates are computed with sets of responses with large
intersections. Interestingly, a similarly high number of responses
was collected on April 14th, with nearly no impact on accuracy.
4. DISCUSSION
The linear regression equation in Figure 1A points to
CoronaSurveys very consistently underestimating the number of
cases by a factor of ∼46%, possibly due to asymptomatic cases.
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FIGURE 1 | Comparison between the serology test and CoronaSurveys, direct correlation (A), and Bland-Altman (B).
TABLE 1 | Percentage (and 95% confidence interval) of infected population per region according to the ENE-COVID serology study (14), CoronaSurveys, and
Covid19Impact (11) (symptom-only model).
ENE-COVID CoronaSurveys Covid19Impact
Region % Infected % Infected Responses Reach % Infected Responses
Andalucia 3.55 3.11 (±0.41) 100 6, 721 2.2 (±0.3) 5, 691
Aragon 5.56 3.19 (±0.41) 44 3, 045 2.0 (±0.3) 1, 463
Asturias 2.20 2.14 (±0.52) 42 2, 987 1.5 (±0.3) 655
Cantabria 4.30 3.19 (±0.96) 16 1, 285 2.8 (±0.3) 497
Castilla y Leon 8.12 5.26 (±0.58) 86 5, 763 3.7 (±0.4) 1, 994
Castilla La Mancha 12.90 8.28 (±0.68) 100 6, 399 8.0 (±0.3) 3, 469
Canarias 3.17 2.44 (±0.74) 26 1, 678 1.4 (±0.2) 1, 052
Catalonia 6.91 4.12 (±0.49) 100 6, 310 2.8 (±0.3) 5, 088
Extremadura 4.13 3.18 (±0.74) 32 2, 168 2.3 (±0.4) 656
Galicia 2.65 3.75 (±0.49) 85 5, 781 1.3 (±0.3) 2, 257
Baleares 3.20 3.02 (±0.76) 33 1, 955 1.9 (±0.3) 1, 222
Murcia 2.10 1.90 (±0.50) 45 2, 835 1.5 (±0.3) 3, 566
Madrid 13.8 8.86 (±0.67) 100 6, 850 6.1 (±0.4) 10, 365
Navarra 6.90 4.32 (±1.16) 16 1, 180 3.6 (±0.4) 580
Basque Country 4.90 5.30 (±0.65) 65 4, 511 1.9 (±0.4) 1, 007
La Rioja 4.90 4.02 (±1.72) 9 498 1.8 (±0.4) 220
Valencia 3.05 2.59 (±0.37) 100 7, 233 1.6 (±0.3) 102, 021
This ratio is consistent with the estimates of the Covid19Impact
study of Oliver et al. (11), which used more than 140, 000
direct survey responses collected on March 28th–30th. It is
also consistent with the reported data on asymptomatic cases
reported by Pollán et al. (14), which found that around a third of
the seropositive participants were asymptomatic (see Table 1).
Concerning the impact of the number of responses as depicted
in Figure 2, we observe how once the minimum number is
reached, further responses will not significantly increase accuracy
unless these come from underreported regions. As depicted in
Figure 3, additional responses from regions where many are
already available will barely have an impact on the global result.
As the great majority of contributions for April 14th were for
Madrid, where we already had many responses available, the
77 new daily responses on April 14th barely had any impact,
while the contributions on April 16th significantly increase the
accuracy of our estimation.
Our study presents a number of limitations. Firstly, as
presented in Table 1, our number of responses in some regions
was limited (e.g., nine responses in La Rioja or 16 in Navarra and
Cantabria). Our own analysis suggests this is not enough to offer
reliable data for these three regions. Additionally, our criteria to
eliminate outliers is heuristic, and may change in the future as we
collect more data.
Nevertheless, despite these limitations, the estimates obtained
in CoronaSurveys show high correlation with serology tests.
Moreover, since the underestimation of our method over all
regions is homogeneous, and consistent with the one third
fraction of asymptomatic reported by Pollán et al. (14), these
estimates can be “corrected” to provide an accurate cumulative
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FIGURE 2 | Convergence of correlation with number of responses (A) and day of the month (B). The line represents the resulting R squared correlation, the dots in
the line represent sampling points. The bars represent the number of new daily responses.
FIGURE 3 | Distribution of new survey responses on April 14 (A) and April 16 (B).
number of cases for each region. We will further evaluate the
robustness of our model as Pollán et al. publish the results of their
three additional serology studies.
In summary, we believe these results strongly support using
open surveys with indirect reporting as amethod to broadly sense
the progress of a pandemic.
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